Skip to content
My WebMD Sign In, Sign Up
New Arthritis Drug Xeljanz Gets FDA Approval
avatar
Caprice_WebMD_Staff posted:
Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis .

Xeljanz is approved for use by patients not helped by methotrexate , the usual first treatment for RA. It's a pill taken twice a day.

Xeljanz is a type of drug called a Janus kinase or JAK inhibitor. Blocking JAK mutes the inflammation responses responsible for RA.
"Xeljanz provides a new treatment option for adults suffering from the debilitating disease of RA who have had a poor response to methotrexate," says Badrul Chowdhury, MD, PhD, the FDA's head of pulmonary, allergy , and rheumatology products.
We must let go of the life we have planned, so as to accept the one that is waiting for us. ~Joseph Campbell
Was this Helpful?
2 of 2 found this helpful
Reply
 
avatar
lex16420 responded:
@25k a year
 
avatar
xperky replied to lex16420's response:
Yikes


Featuring Experts

Scott Zashin, MD is a clinical assistant professor at the University of Texas, Southwestern Medical School and maintains a private practice at Presb...More

Helpful Tips

Dry eyes and dry mouthExpert
Patients with RA may develop dryness of the eyes and mouth due to a condition called secondary Sjogrens Syndrome. The dryness is due to ... More
Was this Helpful?
32 of 39 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems to the
Food and Drug Administration

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.